CALLE DOCTOR FLEMING, 51 | 28036 MADRID, SPAIN
+34 91 3459395
info@oxonepi.com

THERAPEUTIC AREAS

Therapeutic Experience

We help our customers conduct cost-efficient observational studies worldwide

Along with clinical specialists, our team of epidemiologists, statisticians, clinicians, health economists and qualitative researchers conduct effective field, secondary data and hybrid observational studies to achieve our client’s goals.

OXON offers proven experience and a large portfolio of completed studies in a broad range of therapeutic areas and high-profile publications, including original articles appearing in The Lancet.

METABOLIC

read more

CARDIOVASCULAR

read more

ONCOLOGY

read more

NEUROSCIENCE

read more

ORPHAN

read more

IMMUNOLOGY

read more

VACCINES

read more

RESPIRATORY

read more

GASTROENTEROLOGY

read more

OPHTHALMOLOGY

read more

PAEDIATRICS

read more

PREGNANCY

read more

Metabolic 

OXON has working experience on:
• Diabetes
• Osteoporosis
• Gout

We have worked on a pragmatic trial of a Gliflozin (SGLT2i).

We receive scientific consultation from Stuart Pocock, Professor of Medical Statistics, London School of Hygiene & Tropical Medicine, who is an international leader in diabetes trials and registries.

Cardiovascular 

Our staff have worked on studies in Obesity, High blood pressure, Lipids, Anti-coagulants, Anti-thrombotic and Heart failure, having completed studies with cardiovascular and Stroke safety endpoints. Several of these projects have led to full publications in The Lancet, with OXON authors.

Stuart Pocock, Professor of Medical Statistics, London School of Hygiene & Tropical Medicine, who is an international leader in cardiovascular trials and registries and evaluation of Cardiovascular safety issues, consults us in this field.

Oncology

OXON has worked on studies in solid cancers: Lung, Breast, Colorectal, Urothelial, Melanoma, and Haematologic cancers: Multiple myeloma and Leukaemia, Oncologic pain.

We can analyse the Systemic Anti-Cancer Therapy (SACT) database in the UK.

We work together with Clinical oncologists and Haematologists with whom we consult closely.

Neuroscience

OXON has worked on studies in Alzheimer’s disease and other dementias, Parkinson’s disease, Multiple sclerosis, Epilepsy, Schizophrenia, Anti-Psychotics, Anti-depressants, with one publication in The Lancet, among others.

One of our senior clinical epidemiologists is chief author of the international textbook: ´Evidence-based Dementia Practice´, Published by Wiley-Blackwells, Oxford and was Founding Editor of the Cochrane Dementia Group.

Orphan

OXON has worked on a wide range of rare diseases such as studies in Fabry, Gaucher, Pompe, and Spinal Muscular Atrophy. These studies include many different approaches, with emphasis on the use of ultra-rare orphan disease registries.

Immunology

We have worked on studies in Rheumatoid Arthritis, Atopic Dermatitis, Psoriasis, Organ Transplant Rejection, and other medical conditions from an immunologic point of view. We have recently successfully finalised a PAS Evaluation study in Transplant Rejection.

Vaccines

OXON has worked on studies in Influenza, Pneumococcal Disease, Diphtheria-Tetanus-Pertussis, Rotavirus, and Herpes Zoster. Our experience in this field does not only cover PASS studies, but also feasibility assessments and the use of databases in several European countries.

Respiratory

Our motivation in the clinical respiratory field has promoted innovative approaches in feasibility studies, as well as other types of studies related to COPD, Asthma and Allergic Bronchopulmonary Aspergillosis.

Gastroenterology

OXON has worked on studies in Inflammatory Bowel Disease, Liver Disease, Peptic Ulcer, Laxatives, etc. We are currently working on a study that requires strategic skills and experience with PASS studies.

Ophthalmology

We have experience in studies in Keratoconjunctivitis.

Paediatrics

We have worked on several studies involving children: Vaccines, Leukaemia, Rotavirus, and others. We have experience in adapting the study and study documentation such as parental consent and children’s assent forms to the appropriate age group and ensure achievement of the objectives.

Pregnancy

OXON has developed a novel approach to studying drug exposure during pregnancy, with a follow up on pregnancy, birth, infant and childhood outcomes with the use of prospective pregnancy registries and hybrid database approaches.

Contact us! It will only take a minute

CONTACT US